JPS51133264A - Novel 111oxaaprostaglandine homologue * derivatives and production of the same - Google Patents

Novel 111oxaaprostaglandine homologue * derivatives and production of the same

Info

Publication number
JPS51133264A
JPS51133264A JP51049771A JP4977176A JPS51133264A JP S51133264 A JPS51133264 A JP S51133264A JP 51049771 A JP51049771 A JP 51049771A JP 4977176 A JP4977176 A JP 4977176A JP S51133264 A JPS51133264 A JP S51133264A
Authority
JP
Japan
Prior art keywords
homologue
derivatives
novel
production
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP51049771A
Other languages
English (en)
Inventor
Yohanesu Roorensu Geruharudasu
Machiyuusu Koekemoaa Yohanesu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chembro Holdings Pty Ltd
Original Assignee
Chembro Holdings Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chembro Holdings Pty Ltd filed Critical Chembro Holdings Pty Ltd
Publication of JPS51133264A publication Critical patent/JPS51133264A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • C07D307/33Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/18Acyclic radicals, substituted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
JP51049771A 1975-04-30 1976-04-30 Novel 111oxaaprostaglandine homologue * derivatives and production of the same Pending JPS51133264A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA00752806A ZA752806B (en) 1975-04-30 1975-04-30 Novel 11-oxa-prostaglandin analogues derivatives thereof and methods for their preparation

Publications (1)

Publication Number Publication Date
JPS51133264A true JPS51133264A (en) 1976-11-18

Family

ID=25568947

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51049771A Pending JPS51133264A (en) 1975-04-30 1976-04-30 Novel 111oxaaprostaglandine homologue * derivatives and production of the same

Country Status (8)

Country Link
US (1) US4133817A (ja)
JP (1) JPS51133264A (ja)
AU (1) AU501804B2 (ja)
CA (1) CA1084059A (ja)
CH (2) CH623578A5 (ja)
DE (1) DE2618861A1 (ja)
GB (1) GB1540443A (ja)
ZA (1) ZA752806B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US5866602A (en) * 1995-12-22 1999-02-02 Alcon Laboratories, Inc. Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
EP0869794B1 (en) 1995-12-22 2004-08-11 Alcon Laboratories, Inc. Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
US5814660A (en) * 1995-12-22 1998-09-29 Alcon Laboratories, Inc. 9-oxa prostaglandin analogs as ocular hypotensives
WO2000020386A1 (en) * 1998-10-05 2000-04-13 Alcon Laboratories, Inc. Stannane synthesis of prostanoids
US6441196B2 (en) * 2000-05-19 2002-08-27 Alcon, Inc. Processes and novel intermediates for 11-oxa prostaglandin synthesis

Also Published As

Publication number Publication date
ZA752806B (en) 1976-12-29
GB1540443A (en) 1979-02-14
CA1084059A (en) 1980-08-19
US4133817A (en) 1979-01-09
AU501804B2 (en) 1979-06-28
DE2618861A1 (de) 1976-11-11
CH622020A5 (ja) 1981-03-13
CH623578A5 (ja) 1981-06-15
AU1323976A (en) 1977-10-27

Similar Documents

Publication Publication Date Title
GB1542940A (en) Dihydroimidazopyridinones and derivatives of such compounds
JPS5283331A (en) Nnthiolcarbonyl derivatives of nnphosphonomethylglycin
IL46926A0 (en) The preparation of 2-arylamino-2-imidazoline derivatives and certain novel 2-dihaloarylamino-2-imidazoline derivatives
CY1212A (en) Derivatives of perhydro-aza-heterocycles and processes for the production thereof
JPS5246068A (en) Production of llleucinee 133mochilin and compound containing the same
JPS5212118A (en) Production of bicynalhydroester and bicynaldiester
JPS52100464A (en) Production of ribidomycine b derivatives
JPS5287153A (en) Production of indanepentaol derivatives and related compounds
JPS5210267A (en) Production of ll pyrogulutamyllll prolineamide and production thereof
GB1542904A (en) 3-triazolylthio derivatives of ureido-7alpha-methoxy or desmethoxy cephalosporins
JPS51133264A (en) Novel 111oxaaprostaglandine homologue * derivatives and production of the same
JPS537680A (en) Production of 6a*10aatranss hexahydrobenzopyranone derivatives
JPS51136664A (en) Novel 33deoxyy14 betaa hydroxycaldenolide and production of the same
JPS5312897A (en) Production of theaflauin and derivative thereof
JPS52128347A (en) Production of polyiodobenzene derivatives
IL50436A0 (en) Novel 4-hydroxymethyl-2-pyrrolidinone derivatives and their production
JPS51143658A (en) Production of 55*2*22 dihalovynyl**4*44dimethyll 22oxotetrafuran
JPS5219668A (en) Production of 33hydroxyy 1*2*44triazole derivatives
JPS5219690A (en) Production and composition of morphantlysine derivatives
JPS5277083A (en) Nnacyl derivatives of thienamycine
JPS51138668A (en) Production of 211hydroxyy 166pregnenn200one derivatives
JPS51125379A (en) Production of aminopyrole derivatives
JPS5318585A (en) Production of 55fluoruracil derivatives
JPS51133268A (en) Production of benzooxorylcarbamate compound and pestiside containing the same
JPS5212186A (en) Production of mydecamycine derivatives